Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
3
×
boston top stories
deals
3
×
hepatitis b
3
×
life sciences
national blog main
national top stories
alexion pharmaceuticals
alnylam pharmaceuticals
boehringer ingelheim
boston
clinical trials
rna interference
san francisco blog main
alnylam pharmaceutials
arrowhead pharmaceuticals
beijing
brii bio
brii biosciences
china
dicerna pharamceuticals
dicerna pharmaceuticals
eli lilly
fda
glaxosmithkline
gsk
hepatitis b virus
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
johnson & johnson
neurodegenerative diseases
patisiran
primary hyperoxaluria
raleigh-durham
raleigh-durham blog main
raleigh-durham top stories
roche
san francisco top stories
What
medicines
3
×
dicerna
disease
drug
hepatitis
pharma
abandoning
adds
ago
alliance
areas
baggage
biosciences
bio’s
brii
caught
causing
companies
cuts
deal
development
earlier
eye
free
gene
gets
infectious
intended
interference
launched
long
million
mission
new
pay
pharmaceuticals
pipeline
producing
protein
research
Language
unset
Current search:
biotech
×
deals
×
" boston blog main "
×
medicines
×
" hepatitis b "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M